Machine Design

Linear Encoder Showdown: Wired vs. Wireless Read Heads

Linear guideways with built-in encoders are transforming precision motion systems by combining guidance and feedback in one ...
DeshGujarat

100 Applications Approved for Commercial Gas Cylinders in Surat; Priority to Essential Services

Surat: The impact of ongoing conflicts in the Middle East is now being felt at the local level, with disruptions in gas supply leading to a shortage of commercial gas cylinders in Surat city. As per ...
IEEE

Novel Tree Based Priority Encoder Design Technique

Abstract: Priority Encoders (PEs) are quite critical component for digital system design. Authors have proposed a tree based scalable PE design methodology. Observing the modularity, regularity and ...
Seeking Alpha

Priovant Announces FDA Acceptance and Priority Review of New Drug Application for Brepocitinib in Dermatomyositis

FDA assigns PDUFA target action date in the third quarter of calendar year 2026 with launch expected at the end of September 2026 Priority Review supported by positive Phase 3 VALOR results, the first ...
Times Argus

Takeda and Protagonist Announce U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Rusfertide as a Potential First-in-Class Therapy ...

Takeda ( TSE:4502/NYSE:TAK) and Protagonist Therapeutics, Inc. (“Protagonist”) ( NASDAQ:PTGX) today announced that the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) ...
Seeking Alpha

Ultragenyx Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application (BLA) for DTX401 AAV Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa)

NOVATO, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (RARE) today announced the U.S. Food and Drug Administration (FDA or the Agency) has accepted for review the Biologics ...
beinsure

Michigan bill targets auto application rules and motorcycle insurance claim priority

Michigan lawmakers have introduced Senate Bill 782, a proposal to revise auto insurance application rules and clarify how personal protection insurance pays out in motorcycle crashes. The measure ...
Business Wire

U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for ...

NT1 is a chronic, rare neurological disease caused by a loss of orexin and characterized by excessive daytime sleepiness and cataplexy (sudden loss of muscle tone). This results in a spectrum of ...
BioSpace

U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for ...

This FDA Acceptance is a Milestone for People Living with Narcolepsy Type 1 Who Need New and Different Treatment Options Oveporexton is an Orexin Agonist Designed to Restore Orexin Signaling and ...